25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OKYO (OKYO Pharma Ltd ADR) Stock Analysis
Buy, Hold or Sell?

Let's analyze OKYO Pharma Ltd ADR together

I guess you are interested in OKYO Pharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – OKYO Pharma Ltd ADR’s Financial Insights
  • 📈 Technical Analysis (TA) – OKYO Pharma Ltd ADR’s Price Targets

I'm going to help you getting a better view of OKYO Pharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.

1. Quick Overview

1.1. Quick analysis of OKYO Pharma Ltd ADR (30 sec.)










1.2. What can you expect buying and holding a share of OKYO Pharma Ltd ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.17
Expected worth in 1 year
$-0.62
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.45
Return On Investment
-15.6%

For what price can you sell your share?

Current Price per Share
$2.89
Expected price per share
$1.98 - $3.11
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of OKYO Pharma Ltd ADR (5 min.)




Live pricePrice per Share (EOD)
$2.89
Intrinsic Value Per Share
$-4.50 - $-0.14
Total Value Per Share
$-4.67 - $-0.31

2.2. Growth of OKYO Pharma Ltd ADR (5 min.)




Is OKYO Pharma Ltd ADR growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.8m-$2m-$3.8m-65.1%

How much money is OKYO Pharma Ltd ADR making?

Current yearPrevious yearGrowGrow %
Making money-$16.8k-$13.2m$13.2m78,780.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of OKYO Pharma Ltd ADR (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#802 / 874

Most Revenue
#833 / 874

Most Profit
#170 / 874

Most Efficient
#305 / 874
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of OKYO Pharma Ltd ADR?

Welcome investor! OKYO Pharma Ltd ADR's management wants to use your money to grow the business. In return you get a share of OKYO Pharma Ltd ADR.

First you should know what it really means to hold a share of OKYO Pharma Ltd ADR. And how you can make/lose money.

Speculation

The Price per Share of OKYO Pharma Ltd ADR is $2.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of OKYO Pharma Ltd ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in OKYO Pharma Ltd ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.17. Based on the TTM, the Book Value Change Per Share is $-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of OKYO Pharma Ltd ADR.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%0.000.0%-0.39-13.5%-0.17-5.9%-0.13-4.4%-0.13-4.5%
Usd Book Value Change Per Share-0.11-3.9%-0.11-3.9%-0.15-5.1%-0.11-3.8%-0.03-1.2%-0.16-5.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-3.9%-0.11-3.9%-0.15-5.1%-0.11-3.8%-0.03-1.2%-0.16-5.4%
Usd Price Per Share1.49-1.49-1.68-1.06-0.63-0.32-
Price to Earnings Ratio-3,005.30--3,005.30--4.30--1,003.20--601.92--300.96-
Price-to-Total Gains Ratio-13.22--13.22--11.40--12.31--12.31--12.31-
Price to Book Ratio-8.60--8.60--27.77--12.12--7.27--3.64-
Price-to-Total Gains Ratio-13.22--13.22--11.40--12.31--12.31--12.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.89
Number of shares346
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.11-0.03
Usd Total Gains Per Share-0.11-0.03
Gains per Quarter (346 shares)-39.01-12.03
Gains per Year (346 shares)-156.05-48.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-156-1660-48-58
20-312-3220-96-106
30-468-4780-144-154
40-624-6340-193-202
50-780-7900-241-250
60-936-9460-289-298
70-1092-11020-337-346
80-1248-12580-385-394
90-1404-14140-433-442
100-1560-15700-481-490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.015.00.011.8%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%6.011.00.035.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.016.05.9%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%7.010.00.041.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of OKYO Pharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.113-0.1130%-0.147+31%-0.110-2%-0.035-69%-0.156+38%
Book Value Per Share---0.173-0.1730%-0.061-65%-0.049-72%0.001-15239%0.191-191%
Current Ratio--0.2070.2070%0.716-71%1.366-85%1.797-88%15.049-99%
Debt To Asset Ratio--4.8154.8150%1.395+245%2.175+121%1.602+201%0.863+458%
Debt To Equity Ratio----0%-0%0.153-100%0.158-100%0.214-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--43971536.00043971536.0000%53801712.000-18%48886624.000-10%48886624.000-10%48886624.000-10%
Eps--0.0000.0000%-0.391+78780%-0.170+34105%-0.127+25429%-0.129+25872%
Ev To Ebitda Ratio---2792.576-2792.5760%-4.081-100%-1398.328-50%-1398.328-50%-1398.328-50%
Free Cash Flow Per Share---0.280-0.2800%-0.227-19%-0.223-20%-0.150-46%-0.087-69%
Free Cash Flow To Equity Per Share---0.097-0.0970%0.048-302%-0.049-49%0.006-1733%-0.007-93%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.032-3%
Intrinsic Value_10Y_max---0.136----------
Intrinsic Value_10Y_min---4.500----------
Intrinsic Value_1Y_max---0.072----------
Intrinsic Value_1Y_min---0.283----------
Intrinsic Value_3Y_max---0.171----------
Intrinsic Value_3Y_min---1.001----------
Intrinsic Value_5Y_max---0.217----------
Intrinsic Value_5Y_min---1.878----------
Market Cap98076774.000+48%50565534.00050565534.0000%57013488.000-11%35859674.000+41%21515804.400+135%10757902.200+370%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio-16.681-94%-8.600-8.6000%-27.768+223%-12.123+41%-7.274-15%-3.637-58%
Pe Ratio-5829.069-94%-3005.299-3005.2990%-4.296-100%-1003.198-67%-601.919-80%-300.959-90%
Price Per Share2.890+48%1.4901.4900%1.680-11%1.057+41%0.634+135%0.317+370%
Price To Free Cash Flow Ratio-10.334-94%-5.328-5.3280%-7.403+39%-4.244-20%-2.546-52%-1.273-76%
Price To Total Gains Ratio-25.632-94%-13.215-13.2150%-11.401-14%-12.308-7%-12.308-7%-12.308-7%
Quick Ratio--0.1900.1900%0.692-73%1.177-84%1.680-89%23.611-99%
Return On Assets---0.011-0.0110%-2.550+23262%-1.275+11577%-1.376+12502%-2.769+25266%
Return On Equity----0%-0%-0.6140%-0.4950%-3.2210%
Total Gains Per Share---0.113-0.1130%-0.147+31%-0.110-2%-0.035-69%-0.156+38%
Usd Book Value---5879582.000-5879582.0000%-2053237.000-65%-1661805.667-72%38838.400-15239%9584095.411-161%
Usd Book Value Change Per Share---0.113-0.1130%-0.147+31%-0.110-2%-0.035-69%-0.156+38%
Usd Book Value Per Share---0.173-0.1730%-0.061-65%-0.049-72%0.001-15239%0.191-191%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--43971536.00043971536.0000%53801712.000-18%48886624.000-10%48886624.000-10%48886624.000-10%
Usd Eps--0.0000.0000%-0.391+78780%-0.170+34105%-0.127+25429%-0.129+25872%
Usd Free Cash Flow---9490537.000-9490537.0000%-7701158.000-19%-7553809.667-20%-5094127.200-46%-3531747.998-63%
Usd Free Cash Flow Per Share---0.280-0.2800%-0.227-19%-0.223-20%-0.150-46%-0.087-69%
Usd Free Cash Flow To Equity Per Share---0.097-0.0970%0.048-302%-0.049-49%0.006-1733%-0.007-93%
Usd Market Cap98076774.000+48%50565534.00050565534.0000%57013488.000-11%35859674.000+41%21515804.400+135%10757902.200+370%
Usd Price Per Share2.890+48%1.4901.4900%1.680-11%1.057+41%0.634+135%0.317+370%
Usd Profit---16825.460-16825.4600%-13272000.000+78780%-6239941.820+36986%-4723194.892+27972%-6612712.169+39202%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.113-0.1130%-0.147+31%-0.110-2%-0.035-69%-0.156+38%
 EOD+6 -2MRQTTM+0 -0YOY+10 -203Y+10 -215Y+11 -2010Y+15 -17

3.3 Fundamental Score

Let's check the fundamental score of OKYO Pharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5,829.069
Price to Book Ratio (EOD)Between0-1-16.681
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.190
Current Ratio (MRQ)Greater than10.207
Debt to Asset Ratio (MRQ)Less than14.815
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.011
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.854
Ma 20Greater thanMa 502.492
Ma 50Greater thanMa 1001.975
Ma 100Greater thanMa 2001.613
OpenGreater thanClose2.810
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About OKYO Pharma Ltd ADR

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease; in phase 1 clinical trial for the treatment of neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201, which is in preclinical trial for the treatment of dry eye disease and neuropathic chronic pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Fundamental data was last updated by Penke on 2025-06-17 17:27:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit OKYO Pharma Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--92.7%+92.7%
TTM--140.3%+140.3%
YOY--196.4%+196.4%
3Y--248.5%+248.5%
5Y--343.4%+343.4%
10Y--496.2%+496.2%
4.3.1.2. Return on Assets

Shows how efficient OKYO Pharma Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • -1.1% Return on Assets means that OKYO Pharma Ltd ADR generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OKYO Pharma Ltd ADR:

  • The MRQ is -1.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.1%0.0%
TTM-1.1%YOY-255.0%+253.9%
TTM-1.1%5Y-137.6%+136.5%
5Y-137.6%10Y-276.9%+139.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.1%-11.6%+10.5%
TTM-1.1%-11.6%+10.5%
YOY-255.0%-11.4%-243.6%
3Y-127.5%-11.8%-115.7%
5Y-137.6%-12.0%-125.6%
10Y-276.9%-13.7%-263.2%
4.3.1.3. Return on Equity

Shows how efficient OKYO Pharma Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • 0.0% Return on Equity means OKYO Pharma Ltd ADR generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-49.5%+49.5%
5Y-49.5%10Y-322.1%+272.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM--15.0%+15.0%
YOY--14.5%+14.5%
3Y-61.4%-16.9%-44.5%
5Y-49.5%-17.5%-32.0%
10Y-322.1%-19.9%-302.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of OKYO Pharma Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient OKYO Pharma Ltd ADR is operating .

  • Measures how much profit OKYO Pharma Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM--249.0%+249.0%
YOY--208.5%+208.5%
3Y--223.8%+223.8%
5Y--346.1%+346.1%
10Y--475.5%+475.5%
4.3.2.2. Operating Ratio

Measures how efficient OKYO Pharma Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.684-2.684
YOY-3.096-3.096
3Y-3.652-3.652
5Y-4.745-4.745
10Y-6.614-6.614
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of OKYO Pharma Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.21 means the company has $0.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.207. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.207. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.207TTM0.2070.000
TTM0.207YOY0.716-0.509
TTM0.2075Y1.797-1.590
5Y1.79710Y15.049-13.252
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2073.661-3.454
TTM0.2073.846-3.639
YOY0.7164.140-3.424
3Y1.3664.688-3.322
5Y1.7975.746-3.949
10Y15.0496.147+8.902
4.4.3.2. Quick Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Quick Ratio of 0.19 means the company can pay off $0.19 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.190. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.190. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.1900.000
TTM0.190YOY0.692-0.503
TTM0.1905Y1.680-1.490
5Y1.68010Y23.611-21.931
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1902.826-2.636
TTM0.1903.182-2.992
YOY0.6923.786-3.094
3Y1.1774.311-3.134
5Y1.6805.703-4.023
10Y23.6116.454+17.157
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of OKYO Pharma Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of OKYO Pharma Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare OKYO Pharma Ltd ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.81 means that OKYO Pharma Ltd ADR assets are financed with 481.5% credit (debt) and the remaining percentage (100% - 481.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 4.815. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.815. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.815TTM4.8150.000
TTM4.815YOY1.395+3.420
TTM4.8155Y1.602+3.213
5Y1.60210Y0.863+0.738
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8150.329+4.486
TTM4.8150.349+4.466
YOY1.3950.331+1.064
3Y2.1750.340+1.835
5Y1.6020.349+1.253
10Y0.8630.379+0.484
4.5.4.2. Debt to Equity Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.158-0.158
5Y0.15810Y0.214-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y0.1530.450-0.297
5Y0.1580.464-0.306
10Y0.2140.515-0.301
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings OKYO Pharma Ltd ADR generates.

  • Above 15 is considered overpriced but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A PE ratio of -3,005.30 means the investor is paying $-3,005.30 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -5,829.069. Based on the earnings, the company is expensive. -2
  • The MRQ is -3,005.299. Based on the earnings, the company is expensive. -2
  • The TTM is -3,005.299. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5,829.069MRQ-3,005.299-2,823.771
MRQ-3,005.299TTM-3,005.2990.000
TTM-3,005.299YOY-4.296-3,001.003
TTM-3,005.2995Y-601.919-2,403.380
5Y-601.91910Y-300.959-300.959
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5,829.069-2.304-5,826.765
MRQ-3,005.299-2.080-3,003.219
TTM-3,005.299-2.564-3,002.735
YOY-4.296-3.764-0.532
3Y-1,003.198-3.773-999.425
5Y-601.919-6.193-595.726
10Y-300.959-6.833-294.126
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -10.334. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.328. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.328. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.334MRQ-5.328-5.006
MRQ-5.328TTM-5.3280.000
TTM-5.328YOY-7.403+2.075
TTM-5.3285Y-2.546-2.782
5Y-2.54610Y-1.273-1.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.334-3.132-7.202
MRQ-5.328-2.705-2.623
TTM-5.328-3.666-1.662
YOY-7.403-4.405-2.998
3Y-4.244-5.059+0.815
5Y-2.546-8.477+5.931
10Y-1.273-9.304+8.031
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of OKYO Pharma Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -8.60 means the investor is paying $-8.60 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -16.681. Based on the equity, the company is expensive. -2
  • The MRQ is -8.600. Based on the equity, the company is expensive. -2
  • The TTM is -8.600. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.681MRQ-8.600-8.081
MRQ-8.600TTM-8.6000.000
TTM-8.600YOY-27.768+19.167
TTM-8.6005Y-7.274-1.327
5Y-7.27410Y-3.637-3.637
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.6811.953-18.634
MRQ-8.6001.843-10.443
TTM-8.6002.112-10.712
YOY-27.7682.441-30.209
3Y-12.1232.494-14.617
5Y-7.2743.661-10.935
10Y-3.6374.311-7.948
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OKYO Pharma Ltd ADR.

4.8.1. Institutions holding OKYO Pharma Ltd ADR

Institutions are holding 6.133% of the shares of OKYO Pharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Dauntless Investment Group, LLC5.86032.9559198878019887800
2025-03-31Citadel Advisors Llc0.0808027404667532.2013
2025-03-31FNY Investment Advisers, LLC0.05890.015320000200000
2025-03-31Renaissance Technologies Corp0.0411013946-2554-15.4788
2025-03-31HPM Partners LLC0.037801281200
2025-03-31Geode Capital Management, LLC0.035601209000
2024-12-31UBS Group AG0.0088029982473471.0476
2025-03-31Continuum Advisory, LLC0.000105000
2025-03-31Barclays PLC000-961000-100
Total 6.12342.97122078080+1054374+50.7%

4.9.2. Funds holding OKYO Pharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Fidelity Nasdaq Composite Index0.03560.00011209000
Total 0.03560.00011209000.0%

5.3. Insider Transactions

Insiders are holding 34.409% of the shares of OKYO Pharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-15John P BrancaccioBUY166701.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Tax Provision  -6041-19-767-787774-123522
Income Tax Expense  -7651-25-762-787775-12120



5.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,541
Total Liabilities7,421
Total Stockholder Equity-5,880
 As reported
Total Liabilities 7,421
Total Stockholder Equity+ -5,880
Total Assets = 1,541

Assets

Total Assets1,541
Total Current Assets1,538
Long-term Assets3
Total Current Assets
Cash And Cash Equivalents 827
Net Receivables 581
Other Current Assets 130
Total Current Assets  (as reported)1,538
Total Current Assets  (calculated)1,538
+/-0
Long-term Assets
Property Plant Equipment 3
Long-term Assets  (as reported)3
Long-term Assets  (calculated)3
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,421
Long-term Liabilities0
Total Stockholder Equity-5,880
Total Current Liabilities
Accounts payable 6,128
Other Current Liabilities 1,293
Total Current Liabilities  (as reported)7,421
Total Current Liabilities  (calculated)7,421
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock143,113
Retained Earnings -142,523
Accumulated Other Comprehensive Income -11,311
Total Stockholder Equity (as reported)-5,880
Total Stockholder Equity (calculated)-10,722
+/- 4,842
Other
Capital Stock143,113
Cash and Short Term Investments 827
Common Stock Shares Outstanding 29,343
Liabilities and Stockholders Equity 1,541
Net Debt -827
Net Invested Capital -5,880
Net Working Capital -5,883
Property Plant and Equipment Gross 10



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
27,602
38,268
54,133
16,091
42,197
45,199
47,210
34,047
32,184
27,757
2,008
760
597
7,091
4,301
5,204
1,541
1,5415,2044,3017,0915977602,00827,75732,18434,04747,21045,19942,19716,09154,13338,26827,602
   > Total Current Assets 
18,042
30,646
54,133
16,091
17,470
14,575
12,186
6,792
5,371
16,858
0
759
567
6,987
4,295
5,197
1,538
1,5385,1974,2956,987567759016,8585,3716,79212,18614,57517,47016,09154,13330,64618,042
       Cash And Cash Equivalents 
17,970
5,384
26,640
16,072
17,034
14,339
11,824
6,465
5,129
3,925
2,008
628
235
6,889
2,701
4,045
827
8274,0452,7016,8892356282,0083,9255,1296,46511,82414,33917,03416,07226,6405,38417,970
       Short-term Investments 
0
25,254
27,485
0
0
0
0
0
0
16,858
0
0
0
0
0
0
0
000000016,85800000027,48525,2540
       Net Receivables 
0
0
0
0
0
2
261
160
164
154
0
111
326
76
883
980
581
581980883763261110154164160261200000
       Other Current Assets 
71
9
8
19
369
254
257
250
193
19
0
105
268
97
711
171
130
13017171197268105019193250257254369198971
   > Long-term Assets 
9,561
7,621
26,640
16,072
24,727
30,624
35,024
27,256
26,813
23,655
0
1
31
105
5
7
3
375105311023,65526,81327,25635,02430,62424,72716,07226,6407,6219,561
       Property Plant Equipment 
9,561
6,904
0
0
4,464
11,394
19,545
17,314
17,165
15,278
0
1
31
105
5
7
3
375105311015,27817,16517,31419,54511,3944,464006,9049,561
       Goodwill 
0
0
0
0
1,374
1,304
1,071
635
617
535
0
0
0
0
0
0
0
00000005356176351,0711,3041,3740000
       Intangible Assets 
0
718
0
0
18,889
17,926
14,408
9,306
9,032
7,841
0
0
0
0
0
0
0
00000007,8419,0329,30614,40817,92618,889007180
       Other Assets 
0
0
-26,640
-16,072
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000-16,072-26,64000
> Total Liabilities 
145
86
80
79
833
183
248
151
181
259
91
427
737
1,772
1,353
7,257
7,421
7,4217,2571,3531,77273742791259181151248183833798086145
   > Total Current Liabilities 
145
86
80
79
833
183
248
151
181
259
91
427
711
1,707
1,353
7,257
7,421
7,4217,2571,3531,70771142791259181151248183833798086145
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
5
34
0
1,796
0
01,7960345000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,215
0
02,215000000000000000
       Accounts payable 
145
86
80
42
493
74
123
120
124
142
0
382
480
211
518
1,024
6,128
6,1281,024518211480382014212412012374493428086145
       Other Current Liabilities 
0
0
0
37
340
110
26
31
57
75
128
45
89
1,462
836
4,438
1,293
1,2934,4388361,46289451287557312611034037000
   > Long-term Liabilities 
73
60
53
26
308
48
74
81
86
147
0
293
27
65
565
0
0
00565652729301478681744830826536073
> Total Stockholder Equity
27,458
38,182
54,053
16,012
41,341
45,016
46,962
33,896
32,003
27,498
1,917
333
-140
5,319
2,947
-2,053
-5,880
-5,880-2,0532,9475,319-1403331,91727,49832,00333,89646,96245,01641,34116,01254,05338,18227,458
   Common Stock
0
0
0
0
0
90,596
109,780
98,018
95,124
82,588
66,368
89,218
67,519
111,629
123,977
131,386
143,113
143,113131,386123,977111,62967,51989,21866,36882,58895,12498,018109,78090,59600000
   Retained Earnings 
-2,975
12,187
28,964
-9,542
-29,647
-48,159
-66,005
-65,920
-64,712
-55,340
-64,451
-88,966
-85,878
-106,004
-112,426
-125,698
-142,523
-142,523-125,698-112,426-106,004-85,878-88,966-64,451-55,340-64,712-65,920-66,005-48,159-29,647-9,54228,96412,187-2,975
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
30,432
25,995
25,089
25,554
70,988
-12,810
112,809
-9,208
-7,867
-82,752
67,138
89,299
85,738
-306
2,408
3,711
147,955
147,9553,7112,408-30685,73889,29967,138-82,752-7,867-9,208112,809-12,81070,98825,55425,08925,99530,432



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-8
Gross Profit-8-8
 
Operating Income (+$)
Gross Profit-8
Operating Expense-8
Operating Income-16-16
 
Operating Expense (+$)
Research Development8
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense88
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,053
Other Finance Cost-0
Net Interest Income-1,053
 
Pretax Income (+$)
Operating Income-16
Net Interest Income-1,053
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-16,803-15
EBIT - interestExpense = -1,073
-17
1,036
Interest Expense1,053
Earnings Before Interest and Taxes (EBIT)-20-15,750
Earnings Before Interest and Taxes (EBITDA)-16
 
After tax Income (+$)
Income Before Tax-16,803
Tax Provision-22
Net Income From Continuing Ops-16,825-16,825
Net Income-17
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses16
Total Other Income/Expenses Net-11,053
 

Technical Analysis of OKYO Pharma Ltd ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of OKYO Pharma Ltd ADR. The general trend of OKYO Pharma Ltd ADR is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine OKYO Pharma Ltd ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. OKYO Pharma Ltd ADR Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OKYO Pharma Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.11.

The bearish price targets are: 2.12 > 2.05 > 1.98.

Know someone who trades $OKYO? Share this with them.👇

OKYO Pharma Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OKYO Pharma Ltd ADR. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OKYO Pharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OKYO Pharma Ltd ADR. The current macd is 0.24472406.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the OKYO Pharma Ltd ADR price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for OKYO Pharma Ltd ADR. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the OKYO Pharma Ltd ADR price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
OKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartOKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OKYO Pharma Ltd ADR. The current adx is 40.35.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy OKYO Pharma Ltd ADR shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
OKYO Pharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OKYO Pharma Ltd ADR. The current sar is 2.10116296.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
OKYO Pharma Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OKYO Pharma Ltd ADR. The current rsi is 65.85. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
OKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) ChartOKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OKYO Pharma Ltd ADR. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the OKYO Pharma Ltd ADR price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
OKYO Pharma Ltd ADR Daily Stochastic Oscillator ChartOKYO Pharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OKYO Pharma Ltd ADR. The current cci is 121.97.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
OKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) ChartOKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OKYO Pharma Ltd ADR. The current cmo is 35.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
OKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartOKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OKYO Pharma Ltd ADR. The current willr is -3.44827586.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
OKYO Pharma Ltd ADR Daily Williams %R ChartOKYO Pharma Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OKYO Pharma Ltd ADR.

OKYO Pharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OKYO Pharma Ltd ADR. The current atr is 0.21746171.

OKYO Pharma Ltd ADR Daily Average True Range (ATR) ChartOKYO Pharma Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OKYO Pharma Ltd ADR. The current obv is 26,593,717.

OKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) ChartOKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OKYO Pharma Ltd ADR. The current mfi is 70.65.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
OKYO Pharma Ltd ADR Daily Money Flow Index (MFI) ChartOKYO Pharma Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OKYO Pharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

OKYO Pharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.854
Ma 20Greater thanMa 502.492
Ma 50Greater thanMa 1001.975
Ma 100Greater thanMa 2001.613
OpenGreater thanClose2.810
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of OKYO Pharma Ltd ADR with someone you think should read this too:
  • Are you bullish or bearish on OKYO Pharma Ltd ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about OKYO Pharma Ltd ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about OKYO Pharma Ltd ADR.

Receive notifications about OKYO Pharma Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.